Charlotte Haug. Show Affiliations »
Abstract
Mesh: See more » Adverse Drug Reaction Reporting SystemsEthics, BusinessFemaleFinancial SupportHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18HumansMarketingPapillomavirus Infections/prevention & controlPapillomavirus Vaccines/adverse effectsRisk AssessmentUnited StatesUterine Cervical Neoplasms/prevention & controlUterine Cervical Neoplasms/virologyVaccination/standards
Substances: See more » Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18Papillomavirus Vaccines
Year: 2009 PMID: 19690315 DOI: 10.1001/jama.2009.1215
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272